Plasmonix, Inc. — Form D
Plasmonix, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2011-06-21. The offering totals $2.0M, of which $1.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-06-21
- Form: D
- Accession: 0001521534-11-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $1.2M
- Remaining: $783K
- Investors: 18
- Date of first sale: 2011-06-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-161560
Issuer
- Name: Plasmonix, Inc.
- CIK: 0001521534
- Entity type: Corporation
- Jurisdiction: MARYLAND
- Incorporated: 2009
- Address: 9119 GAITHER ROAD, GAITHERSBURG, MD, 20877
- Phone: 410-625-5939
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Christopher D Geddes | Executive Officer | Baltimore, MD |
| John W Holaday | Director | ROCKVILLE, MD |
| John W Holaday | Executive Officer | ROCKVILLE, MD |
| Steven W Meltzer | Director | Gaithersburg, MD |
| Edward M Rudnic, PhD | Director | Gaithersburg, MD |
| Jesse Baumgold, PhD | Director | Bethesda, MD |
| Jesse Baumgold, PhD | Executive Officer | Bethesda, MD |
| David W Manyak | Director | Gaithersburg, MD |
| William M Gust, II | Director | Baltimore, MD |
| William M Gust, II | Executive Officer | Baltimore, MD |
| Jesse W Baumgold, PhD | Director | Bethesda, MD |
| Sean M Higgins, PhD | Executive Officer | Baltimore, MD |
| Jesse E Baumgold, PhD | Director | Bethesda, MD |
| James E Russo | Executive Officer | Baltimore, MD |
Other filings by this issuer (5)
More